US Stock MarketDetailed Quotes

VRAX Virax Biolabs

Watchlist

2.0200
0.00000.00%

Trading Nov 27 15:16 ET

8.77MMarket Cap-773P/E (TTM)

Virax Biolabs Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Quarterly+Annual

YOY

Hide blank lines

(FY)Mar 31, 2024

(FY)Mar 31, 2023

(FY)Mar 31, 2022

(FY)Mar 31, 2021

(FY)Mar 31, 2020

Total revenue

1,727.11%156.42K

8.56K

23.97%123.82K

99.88K

Operating revenue

1,727.11%156.42K

--8.56K

--0

23.97%123.82K

--99.88K

Cost of revenue

966.18%105.83K

9.93K

146.19%133.25K

54.13K

Gross profit

3,806.23%50.59K

-1.37K

-120.62%-9.43K

45.75K

Operating expense

7.42%6.16M

230.59%5.73M

172.98%1.73M

-8.88%635.1K

696.99K

Selling and administrative expenses

29.35%4.59M

173.25%3.55M

152.47%1.3M

-15.59%514.88K

--609.99K

-Selling and marketing expense

----

643.86%57.2K

--7.69K

-General and administrative expense

29.35%4.59M

173.25%3.55M

184.03%1.3M

-24.01%457.68K

--602.3K

Research and development costs

-28.33%1.56M

402.45%2.18M

260.79%433.74K

38.19%120.22K

--87K

Operating profit

-6.51%-6.11M

-230.67%-5.73M

-168.98%-1.73M

1.03%-644.54K

-651.24K

Net non-operating interest income expense

-73.77%-26.88K

-0.19%-15.47K

46.10%-15.44K

68.42%-28.64K

-90.69K

Non-operating interest expense

73.77%26.88K

0.19%15.47K

-46.10%15.44K

-68.42%28.64K

--90.69K

Other net income (expense)

-308.67%-606.12K

38,674.50%290.47K

-383.08%-753

-89.23%266

2.47K

Special income (charges)

---390.36K

--0

----

-Less:Impairment of capital assets

--390.36K

--0

----

Other non- operating income (expenses)

-174.28%-215.77K

38,674.50%290.47K

-383.08%-753

-89.23%266

--2.47K

Income before tax

-23.48%-6.74M

-211.90%-5.46M

-160.04%-1.75M

9.00%-672.92K

-739.46K

Income tax

Net income

-23.48%-6.74M

-211.90%-5.46M

-160.04%-1.75M

9.00%-672.92K

-739.46K

Net income continuous Operations

-23.48%-6.74M

-211.90%-5.46M

-160.04%-1.75M

9.00%-672.92K

---739.46K

Minority interest income

-1,975.46%-5.58K

99.34%-269

-87.15%-41.04K

24.44%-21.93K

-29.02K

Net income attributable to the parent company

-23.38%-6.73M

-219.37%-5.46M

-162.50%-1.71M

8.37%-650.98K

-710.44K

Preferred stock dividends

Other preferred stock dividends

Net income attributable to common stockholders

-23.38%-6.73M

-219.37%-5.46M

-162.50%-1.71M

8.37%-650.98K

-710.44K

Basic earnings per share

34.50%-3.36

-241.46%-5.13

-162.50%-1.5024

8.37%-0.5723

-0.6246

Diluted earnings per share

34.50%-3.36

-241.46%-5.13

-162.50%-1.5024

8.37%-0.5723

-0.6246

Dividend per share

Currency Unit

USD

Audit Opinions

Unqualified Opinion

Unqualified Opinion with Explanatory Notes

	(FY)Mar 31, 2024	(FY)Mar 31, 2023	(FY)Mar 31, 2022	(FY)Mar 31, 2021	(FY)Mar 31, 2020
Total revenue	1,727.11%156.42K	8.56K	0	23.97%123.82K	99.88K
Operating revenue	1,727.11%156.42K	--8.56K	--0	23.97%123.82K	--99.88K
Cost of revenue	966.18%105.83K	9.93K	0	146.19%133.25K	54.13K
Gross profit	3,806.23%50.59K	-1.37K	0	-120.62%-9.43K	45.75K
Operating expense	7.42%6.16M	230.59%5.73M	172.98%1.73M	-8.88%635.1K	696.99K
Selling and administrative expenses	29.35%4.59M	173.25%3.55M	152.47%1.3M	-15.59%514.88K	--609.99K
-Selling and marketing expense	----	----	----	643.86%57.2K	--7.69K
-General and administrative expense	29.35%4.59M	173.25%3.55M	184.03%1.3M	-24.01%457.68K	--602.3K
Research and development costs	-28.33%1.56M	402.45%2.18M	260.79%433.74K	38.19%120.22K	--87K
Operating profit	-6.51%-6.11M	-230.67%-5.73M	-168.98%-1.73M	1.03%-644.54K	-651.24K
Net non-operating interest income expense	-73.77%-26.88K	-0.19%-15.47K	46.10%-15.44K	68.42%-28.64K	-90.69K
Non-operating interest expense	73.77%26.88K	0.19%15.47K	-46.10%15.44K	-68.42%28.64K	--90.69K
Other net income (expense)	-308.67%-606.12K	38,674.50%290.47K	-383.08%-753	-89.23%266	2.47K
Special income (charges)	---390.36K	--0	--0	----	----
-Less:Impairment of capital assets	--390.36K	--0	--0	----	----
Other non- operating income (expenses)	-174.28%-215.77K	38,674.50%290.47K	-383.08%-753	-89.23%266	--2.47K
Income before tax	-23.48%-6.74M	-211.90%-5.46M	-160.04%-1.75M	9.00%-672.92K	-739.46K
Income tax	0	0	0	0	0
Net income	-23.48%-6.74M	-211.90%-5.46M	-160.04%-1.75M	9.00%-672.92K	-739.46K
Net income continuous Operations	-23.48%-6.74M	-211.90%-5.46M	-160.04%-1.75M	9.00%-672.92K	---739.46K
Minority interest income	-1,975.46%-5.58K	99.34%-269	-87.15%-41.04K	24.44%-21.93K	-29.02K
Net income attributable to the parent company	-23.38%-6.73M	-219.37%-5.46M	-162.50%-1.71M	8.37%-650.98K	-710.44K
Preferred stock dividends
Other preferred stock dividends
Net income attributable to common stockholders	-23.38%-6.73M	-219.37%-5.46M	-162.50%-1.71M	8.37%-650.98K	-710.44K
Basic earnings per share	34.50%-3.36	-241.46%-5.13	-162.50%-1.5024	8.37%-0.5723	-0.6246
Diluted earnings per share	34.50%-3.36	-241.46%-5.13	-162.50%-1.5024	8.37%-0.5723	-0.6246
Dividend per share
Currency Unit	USD	USD	USD	USD	USD
Audit Opinions	Unqualified Opinion	Unqualified Opinion with Explanatory Notes	Unqualified Opinion with Explanatory Notes	--	--

Analysis

Analyst Rating

No Data

Price Target

No Data

Heat List

Overall

No Data

Investment Theme

Mpox (monkeypox)

Intraday+0.91%